Some effect of metformin on insulin resistance in an infant with leprechaunism

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 10, 2006, Pages 1257-1261

  Atabek, Emre Mehmet ^a   Pirgon, Ozgur ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Insulin glargine; Leprechaunism; Metformin; Therapy

Indexed keywords

GLUCOSE; INSULIN; INSULIN GLARGINE; METFORMIN;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BREAST HYPERPLASIA; CASE REPORT; CLINICAL FEATURE; DEATH; DISEASE SEVERITY; EYE MALFORMATION; FAILURE TO THRIVE; GROWTH RETARDATION; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPEROSMOLAR COMA; IMMUNOREACTIVITY; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; LARGE EAR; LEPRECHAUNISM; LIPOATROPHY; LOW SET EAR; MALE; MICROGNATHIA; PENIS DISEASE; PHENOTYPE; POSTNATAL GROWTH; SUBCUTANEOUS FAT;

EID: 37849186351     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.10.1257     Document Type: Article

References (17)

1. Moller DE, Flier JS. Insulin resistance mechanism, syndromes, and implications. N Engl J Med 1991; 325: 938-948.
2. Mantzoros CS, Flier JS. Insulin resistance: the clinical spectrum. In: Mazzaferi E, ed. Advances in Endocrinology and Metabolism. St. Louis, MO: Mosby Year Book, 1995; 193-232.
3. Donohue WL, Uchida I. Leprechaunism: a euphemism for a rare familial disorder. J Pediatr 1954; 45: 505-519.
4. Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA, Giannella-Neto D. Genotype-phenotype correlation in inherited severe insulin resistance. Hum Mol Genet 2002; 11: 1465-1475.
5. Mantzoros CS, Moses AC. Treatment of severe insulin resistance. In: Azziz R, Nestler JE, Dewailly D, eds. Androgen excess disorders in women, Philadelphia, PA: Lippincott Raven, 1997; 247-255.
6. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER. Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 1991; 34: 675-679.
7. Grant M, Russell B, Fitzgerald C, Merimee TJ. Insulin-like growth factors in vitreous. Studies in control and diabetics subjects with neovascularization, Diabetes 1986; 35: 416-420.
8. Dills DG, Moss SE, Klein R, Klein BEK. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes 1991; 40: 1725-1730.
9. Hammerman MR, Miller SB. Renal cellular biology of growth hormone and insulin-like growth factor I. Pediatr Nephrol 1991; 5: 505-508.
10. Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85: 4889-4893.
11. Mehls O, Irzynjec T, Ritz E, Eden S, Kovacs G, Klaus G, Floege J, Mall G. Effects of rhGH and rhIGF-I on renal growth and morphology. Kidney Int 1993; 44: 1251-1258.
12. Cochran E, Young JR, Sebring N, DePaoli A, Oral EA, Gorden P. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. J Clin Endocrinol Metab. 2004; 89: 1548-1554.
13. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes) - a 30-year prospective. Medicine 2004; 83: 209-222.
14. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334: 574-579.
15. McKeage K, Goa KL. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus. Drugs 2001; 11: 1599-624.
16. Bahr M, Kolter T, Seipke G, Eckel J. Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells. Eur J Pharmacol 1996; 320: 259-265.
17. LeRoith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 2001; 22: 53-74.